$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Types of adverse reactions of Ordesibat (Belvi) and how to scientifically reduce risks
2026-02-01 22:25:32
Check Details
Scientific advice on how long to take donepezil (Aricept) before you need to stop taking it and rest
2026-02-01 22:25:32
Check Details
Standard usage and dosage of Fidaxomicin and dosage adjustment methods for different patients
2026-02-01 22:25:32
Check Details
Ponatinib belongs to which generation of targeted drugs and its positioning significance in treatment
2026-02-01 22:25:32
Check Details
How many milligrams of Trelagliptin is best to take at one time and analysis of medication recommendations
2026-02-01 22:25:32
Check Details
The latest price trend and purchasing channel reference of inavolisib
2026-02-01 22:25:32
Check Details
Abatacept (Enresu) dosage and dosage recommendations for different patients
2026-02-01 22:25:32
Check Details
Analysis of how many years Almonertinib usually needs to be taken and the duration of treatment
2026-02-01 22:25:32
Check Details
Common reasons for the efficacy of Leborexan (Daveco) to fail and methods to improve its efficacy
2026-02-01 22:25:32
Check Details
Common side effects and scientific treatment methods of Mavakatai
2026-02-01 22:25:32
Check Details
Summary of precautions while taking tenofovir alafenamide tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
Vorasidenib-VORANIGO drug information and detailed explanation of Vorasidenib ingredients
2026-02-01 22:25:32
Check Details
1
2
...
1951
1952
1953
1954
1955
1956
1957
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma